Johnson & Johnson Releases 2020 Health for Humanity Report Highlighting Performance and Progress on Environmental, Social and Governance Priorities

NEW BRUNSWICK, N.J., June 9, 2021 – Johnson &Johnson (NYSE: JNJ) today published the 2020 Health for Humanity Report (Report), which serves as the Company’s annual disclosure on environmental, social and governance (ESG) performance and illustrates progress toward fulfilling its corporate purpose to change the trajectory of health for humanity. The Report documents the Company’s performance and provides information on how the Company generates long-term social, environmental and economic value for all stakeholders; provides an accounting of the final year of progress against the Johnson &Johnson Health for Humanity 2020 Goals and U.N. Sustainable Development Goals Commitment; and details new Health for Humanity 2025 Goals.“As our world continues to grapple with concurrent and converging health crises, the need to prioritize public health as the foundation for a thriving global economy and society has never been more urgent or more clear,” said Alex Gorsky, Chairman and Chief Executive Officer, Johnson &Johnson. “While our company has been taking on the world’s biggest health challenges for over a century and we are proud of the incredible progress against the 2020 Goals detailed in this year’s Report, we know we must continue to invest in sustainable ways to bring life-enhancing healthcare products and solutions to everyone, everywhere.”Highlights from the Report include: Our COVID-19 Response EffortsAn overvie...
Source: Johnson and Johnson - Category: Pharmaceuticals Tags: Our Company Source Type: news

Related Links:

NEW BRUNSWICK, N.J. (October 12, 2021) – Johnson &Johnson (NYSE: JNJ) today announced that Paul Stoffels M.D., currently Vice Chairman of the Executive Committee and Chief Scientific Officer of Johnson &Johnson, will retire from the Company effective December 31, 2021.As the Vice Chairman of the Executive Committee and Chief Scientific Officer, Dr. Stoffels spearheaded the company’s research and product pipeline leading teams across sectors to set the company-wide mandate to discover and develop transformational healthcare solutions. Under his leadership, Johnson &Johnson revitalized its innovation ...
Source: Johnson and Johnson - Category: Pharmaceuticals Tags: Our Company Source Type: news
On Oct. 6, the World Health Organization recommended use of the first vaccine to fight malaria. The decision is momentous and highly anticipated for many reasons: among them is that this is the first vaccine to help reduce the risk of deadly severe malaria in young children in Sub-Saharan Africa, where the disease remains a leading killer. The vaccine offers hope that there can be a circle of learning from one pandemic to the next. Malaria, our oldest pandemic, may offer insights on how we can survive contemporary scourges like COVID-19. Malaria evolved at least 2.5 million years ago and first infected humans in rural part...
Source: TIME: Science - Category: Science Authors: Tags: Uncategorized health healthscienceclimate Source Type: news
Psychiatriki. 2021 Aug 5. doi: 10.22365/jpsych.2021.025. Online ahead of print.ABSTRACTSocial stigma has long been defined by Ervin Goffman as an attribute that it is deeply discrediting and reduces the individual who bears it from a whole and usual person to a tarnished one, unfit to be included into the mainstream society.1 As stigma spans time and space and has been documented in other social species such as ants and chimpanzees, one might argue for its adaptive potential. Neuberg and colleagues2 have suggested that humans generate stigmas against threats to effective group functioning, with a notable case being infecti...
Source: Psychiatriki - Category: Psychiatry Authors: Source Type: research
More News: Cardiology | COVID-19 | Ebola | Ebola Vaccine | Economy | Environmental Health | Government | Health Management | Heart | International Medicine & Public Health | Learning | Legislation | Medical Ethics | Midwifery | Nurses | Nursing | Outbreaks | Pandemics | Partnerships | Pharmaceuticals | Science | Strategic Planning | Training | Tuberculosis | United Nations | Universities & Medical Training | USA Health | Vaccines